Expanding the phenotype of hereditary renal cell carcinoma syndromes: Implications for surveillance and management. August 27, 2026 Radiologic, Pathologic, and Deep Learning Predictors of Response to ...
Conventional imaging is increasingly being replaced by Prostate-specific membrane antigen-directed PET (PSMA-PET) worldwide, and thus, novel prostate cancer risk groups based on PSMA-PET are needed ...
For patients with metastatic hormone-sensitive prostate cancer who achieve deep prostate-specific antigen responses with androgen deprivation therapy plus an androgen receptor pathway inhibitor, ...
Lorelei Mucci reports on a JNCI analysis of five dietary patterns and mortality in approximately 6,000 men with prostate cancer. The cohort came from the Health Professionals Follow-Up Study, with ...
Focal therapy (FT) in high-risk or very high-risk prostate cancer (CaP) is not guideline-recommended. However, it may be occasionally used, but its effect on cancer-specific mortality (CSM) relative ...
Background and objectives Partial nephrectomy (PN) is the gold standard for small renal tumors, preserving nephrons without compromising oncologic outcomes. However, PN carries a higher complication ...
Postoperative infections are an emerging concern in endourology. This study reports an outbreak of urinary tract infections associated with Pseudomonas aeruginosa (PA) in patients who underwent stone ...
To evaluate whether prostate size influences perioperative, urinary, and sexual outcomes following Aquablation for benign prostatic hyperplasia (BPH), by comparing men with prostates < 80 cc and ≥ 80 ...